Cargando…
Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression
NF-κB signaling is a key regulator of inflammation and atherosclerosis. NF-κB cooperates with bromodomain-containing protein 4 (BRD4), a transcriptional and epigenetic regulator, in endothelial inflammation. This study aimed to investigate whether BRD4 inhibition would prevent the proinflammatory re...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692972/ https://www.ncbi.nlm.nih.gov/pubmed/36364277 http://dx.doi.org/10.3390/molecules27217453 |
_version_ | 1784837410941566976 |
---|---|
author | Shahid, Sidra Pantakani, Marlena Binder, Lutz Fischer, Andreas Pantakani, Krishna Asif, Abdul R. |
author_facet | Shahid, Sidra Pantakani, Marlena Binder, Lutz Fischer, Andreas Pantakani, Krishna Asif, Abdul R. |
author_sort | Shahid, Sidra |
collection | PubMed |
description | NF-κB signaling is a key regulator of inflammation and atherosclerosis. NF-κB cooperates with bromodomain-containing protein 4 (BRD4), a transcriptional and epigenetic regulator, in endothelial inflammation. This study aimed to investigate whether BRD4 inhibition would prevent the proinflammatory response towards TNF-α in endothelial cells. We used TNF-α treatment of human umbilical cord-derived vascular endothelial cells to create an in vitro inflammatory model system. Two small molecule inhibitors of BRD4—namely, RVX208 (Apabetalone), which is in clinical trials for the treatment of atherosclerosis, and JQ1—were used to analyze the effect of BRD4 inhibition on endothelial inflammation and barrier integrity. BRD4 inhibition reduced the expression of proinflammatory markers such as SELE, VCAM-I, and IL6 in endothelial cells and prevented TNF-α-induced endothelial tight junction hyperpermeability. Endothelial inflammation was associated with increased expression of the heparin-binding growth factor midkine. BRD4 inhibition reduced midkine expression and normalized endothelial permeability upon TNF-α treatment. In conclusion, we identified that TNF-α increased midkine expression and compromised tight junction integrity in endothelial cells, which was preventable by pharmacological BRD4 inhibition. |
format | Online Article Text |
id | pubmed-9692972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96929722022-11-26 Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression Shahid, Sidra Pantakani, Marlena Binder, Lutz Fischer, Andreas Pantakani, Krishna Asif, Abdul R. Molecules Article NF-κB signaling is a key regulator of inflammation and atherosclerosis. NF-κB cooperates with bromodomain-containing protein 4 (BRD4), a transcriptional and epigenetic regulator, in endothelial inflammation. This study aimed to investigate whether BRD4 inhibition would prevent the proinflammatory response towards TNF-α in endothelial cells. We used TNF-α treatment of human umbilical cord-derived vascular endothelial cells to create an in vitro inflammatory model system. Two small molecule inhibitors of BRD4—namely, RVX208 (Apabetalone), which is in clinical trials for the treatment of atherosclerosis, and JQ1—were used to analyze the effect of BRD4 inhibition on endothelial inflammation and barrier integrity. BRD4 inhibition reduced the expression of proinflammatory markers such as SELE, VCAM-I, and IL6 in endothelial cells and prevented TNF-α-induced endothelial tight junction hyperpermeability. Endothelial inflammation was associated with increased expression of the heparin-binding growth factor midkine. BRD4 inhibition reduced midkine expression and normalized endothelial permeability upon TNF-α treatment. In conclusion, we identified that TNF-α increased midkine expression and compromised tight junction integrity in endothelial cells, which was preventable by pharmacological BRD4 inhibition. MDPI 2022-11-02 /pmc/articles/PMC9692972/ /pubmed/36364277 http://dx.doi.org/10.3390/molecules27217453 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shahid, Sidra Pantakani, Marlena Binder, Lutz Fischer, Andreas Pantakani, Krishna Asif, Abdul R. Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression |
title | Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression |
title_full | Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression |
title_fullStr | Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression |
title_full_unstemmed | Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression |
title_short | Small Molecule BRD4 Inhibitors Apabetalone and JQ1 Rescues Endothelial Cells Dysfunction, Protects Monolayer Integrity and Reduces Midkine Expression |
title_sort | small molecule brd4 inhibitors apabetalone and jq1 rescues endothelial cells dysfunction, protects monolayer integrity and reduces midkine expression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692972/ https://www.ncbi.nlm.nih.gov/pubmed/36364277 http://dx.doi.org/10.3390/molecules27217453 |
work_keys_str_mv | AT shahidsidra smallmoleculebrd4inhibitorsapabetaloneandjq1rescuesendothelialcellsdysfunctionprotectsmonolayerintegrityandreducesmidkineexpression AT pantakanimarlena smallmoleculebrd4inhibitorsapabetaloneandjq1rescuesendothelialcellsdysfunctionprotectsmonolayerintegrityandreducesmidkineexpression AT binderlutz smallmoleculebrd4inhibitorsapabetaloneandjq1rescuesendothelialcellsdysfunctionprotectsmonolayerintegrityandreducesmidkineexpression AT fischerandreas smallmoleculebrd4inhibitorsapabetaloneandjq1rescuesendothelialcellsdysfunctionprotectsmonolayerintegrityandreducesmidkineexpression AT pantakanikrishna smallmoleculebrd4inhibitorsapabetaloneandjq1rescuesendothelialcellsdysfunctionprotectsmonolayerintegrityandreducesmidkineexpression AT asifabdulr smallmoleculebrd4inhibitorsapabetaloneandjq1rescuesendothelialcellsdysfunctionprotectsmonolayerintegrityandreducesmidkineexpression |